-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse StuttgartSymbol NB11
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
786.963.072 oder 894.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
30 oder 110 Mitarbeiter
5 ETFs die in Vaxart investieren
Dir gefallen die Informationen zu Vaxart?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Vaxart?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Vaxart?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Vaxart?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
29 News & Informationen zur Vaxart Aktie
Trending Penny Stocks To Buy For Under $3 Right Now
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board Of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 23, 2021 /PRNewswire/ — Vaxart, Inc. VXRT today announced the addition of Julie M. Cherrington, Ph.D., to the company's
Vaxart Announces Creation of New Scientific and Clinical Advisory Board
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2021 /PRNewswire/ — Vaxart, Inc. (NASDAQ: VXRT), today announced the creation of an eight-member Scientific…
Is the Options Market Predicting a Spike in Vaxart (VXRT) Stock?
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
4 Penny Stocks On Robinhood To Watch This Week
Analysts Estimate VAXART, INC. (VXRT) to Report a Decline in Earnings: What to Look Out for
VAXART, INC. (VXRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
Vaxart's Booster Study Of Oral Norovirus Vaccine Yields Encouraging Immune Responses
(RTTNews) – Shares of Vaxart Inc. (VXRT) are up more than 11% at $9.12 in pre-market trading Thursday, following encouraging news from the company…
Vaxart stock rises with booster effect of vaccine platform (NASDAQ:VXRT)
Vaxart (VXRT) has climbed ~11.8% in the pre-market after the company said its oral vaccine platform boosted the immune response in those who were vaccinated with its oral vaccine more…
Vaxart : Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine
SOUTH SAN FRANCISCO, Calif., July 29, 2021 /PRNewswire/ — Vaxart, Inc. today announced that it has shown for the first time in clinical trials that its oral tablet… | July 29, 2021
Vaxart Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine
/PRNewswire/ — Vaxart, Inc. (Nasdaq: VXRT) today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform…
3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street
Analysts' high-water price targets imply some serious gains for these companies.
3 Small-Cap Stocks to Buy in July
With the summer of recovery under way, these growth stocks could be your best bet.
Vaxart (VXRT) Enters an Agreement With Altesa for Antiviral
Vaxart (VXRT) enters a licensing agreement with Altesa Biosciences, Inc., whereby the latter gets rights to develop, manufacture and commercialize vapendavir.
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Milestone payments up to $130 million and royalties for global Vapendavir sales Vapendavir has demonstrated activity against a broad spectrum of…
Is Vaxart, Inc. (VXRT) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,…
Shot in the arm for companies with Covid-19 deals
PETALING JAYA: As Malaysia’s Covid-19 vaccination programme picks up steam, companies that have ventured into the procurement and distribution of vacc…
5 Sizzling Stocks To Buy Now Trading Under $10 With Massive Upside Potential – 24
Here's a look at five stocks, all with serious analyst coverage, currently selling for less than $10 a share.
Is Now The Time To Buy Stock Or Options In Apple, PayPal, Square Or Vaxart?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Mov…
COVID-Impfung ohne Spritze – ein offenes Rennen
Wer ein Vakzine zum Schlucken zustandebringt, der knackt den Jackpot. Denn in der armen Welt sind die heutigen Vakzine nicht massentauglich.
Is Vaxart Stock a Buy?
Can this small-cap biotech be part of the solution in the ongoing fight against COVID-19?
Should You Buy Vaxart Stock?
This high-flying biotech stock just might have more room to run. But it's risky.
3 Top Small-Cap Stocks to Buy in January
Investors can start the new year off right by digging into these three small but fiery stocks.
Why Vaxart Stock Plunged 28.5% in December
The tiny biotech had been riding higher on hope for its oral coronavirus vaccine.
3 coronavirus stocks poised to soar in 2021
They’re risky but could deliver huge returns in the new year.
3 Coronavirus Stocks Poised to Soar in 2021
They’re risky but could deliver huge returns in the new year.
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 2020
These clinical-stage drug developers were unstoppable last year.
Doug Noland’s Credit Bubble Bulletin: No Sugarcoating 2020
These Were the 3 Best Coronavirus Stocks of 2020
Not all of them were COVID-19 vaccine makers.